Clinical trials
Lung Diseases, Interstitial trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
120 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 8 |
| 2015 | 3 |
| 2016 | 9 |
| 2017 | 3 |
| 2018 | 9 |
| 2019 | 16 |
| 2020 | 15 |
| 2021 | 12 |
| 2022 | 11 |
| 2023 | 19 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 120 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 5 |
| Guangzhou Institute of Respiratory Disease | 5 |
| Hospices Civils de Lyon | 3 |
| Pulmonary Care and Research Collaborative Limited | 3 |
| Sheba Medical Center | 3 |
| University of Zurich | 3 |
| Central Hospital, Nancy, France | 2 |
| First Affiliated Hospital Xi'an Jiaotong University | 2 |
| Hospital do Coracao | 2 |
| Laval University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases, Interstitial | 120 |
| Pulmonary Disease, Chronic Obstructive | 19 |
| Idiopathic Pulmonary Fibrosis | 15 |
| Pulmonary Fibrosis | 15 |
| Arthritis, Rheumatoid | 12 |
| COVID-19 | 7 |
| Connective Tissue Diseases | 6 |
| Sarcoidosis | 6 |
| Scleroderma, Systemic | 6 |
| Dyspnea | 5 |
Trials
Showing 76 to 100 of 120. Each trial links to its page on Pharma Observatory.
20 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.